HCLTECH
Hcl Technologies Limited (hcltech) to Acquire Robotiq.ai, Boosting Enterprise RPA Capabilities
HCL Technologies Limited (HCLTECH) announces acquisition of Robotiq.ai, enhancing enterprise RPA capabilities with a €9m deal.
HCL Technologies Limited (HCLTECH) announced its intent to acquire Robotiq.ai, a leading provider of enterprise Robotic Process Automation (RPA) platform, based in Zagreb, Croatia. This acquisition aims to add enterprise RPA capabilities to HCL UnO Agentic, strengthening end-to-end orchestration across AI agents and enterprise applications.
Strategic Move for Enhanced Automation
HCLSoftware, the software business division of HCLTech, is witnessing growing enterprise demand for AI systems that not only reason but execute work reliably across complex business environments. Robotiq.ai’s RPA platform is used in large banks, insurance groups, and telecom providers and is built with ISO-certified security, audit logs, and flexible deployment options, making the platform reliable and secure.
Expanding Enterprise Reach
The acquisition is expected to close in November 2026 and will provide Robotiq.ai’s technology with the enterprise reach, scale, and platform of HCLSoftware. This move will help customers confidently deploy and scale agentic AI across their operations, as stated by Kalyan Kumar, President, HCLSoftware.
As a result, HCL Technologies Limited is set to bolster its AI-driven vision of the Digital+ future by integrating Robotiq.ai’s capabilities into its existing offerings, thus driving innovation in enterprise automation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of HCL Technologies Limited
HCL Technologies Limited belongs to the Technology › Information Technology Services sector. Here’s a quick read on where the business and the stock stand today.
HCL drops 19.6% over three months and trades near its 52-week lows. The PEG stands at 4.64 — severely stretched. Any earnings miss could trigger a sharp de-rating. D/E stands at 0.09 with a 7.86% dividend yield. Furthermore, the business records zero revenue dips and zero loss quarters in five years — a fortress balance sheet. The stock gains 5.2% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 8.7% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of HCL Technologies Limited.
HCLTECH
Hcl Technologies Limited Expands Partnership with Guardian Life for Ai-driven Modernization
HCL Technologies Limited (HCLTECH) expands partnership with Guardian Life for AI-driven modernization, acquiring Guardian India for US $10.5M.
HCL Technologies Limited (HCLTECH) announced a new seven-year agreement with Guardian Life Insurance Company of America, expanding their collaboration to advance Guardian’s AI-powered modernization across technology and operations to support long-term business growth. Through this partnership, HCLTech aims to accelerate value realization and efficiency for Guardian through differentiated experiences and reduced friction, while creating AI-led solutions and IP for the insurance industry.
Strategic Expansion
The partnership will see HCLTech acquiring Guardian India, a high-impact global capability center with nearly 2,000 employees. This acquisition will integrate specialized talent supporting technology, operations, and shared services, playing a vital role in advancing Guardian’s transformation. Karunakaran Azhisur, Country Head of Guardian India, will join HCLTech to lead this Strategic Business Unit.
Driving Operational Excellence
HCLTech will expand the use of its AI Service Transformation Platform, AI Force, to create and deploy agentic capabilities for the business, further advancing AI adoption and innovation. These capabilities will align with Guardian’s product operating model and help create a more resilient delivery foundation that can scale with the business.
This expanded partnership is another testament to HCLTech’s leadership in the insurance industry and reflects the strength of the relationship with Guardian to drive their AI-enabled journey, as well as a shared focus on scaling AI and modernizing operations.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of HCL Technologies Limited
HCL Technologies Limited belongs to the Technology › Information Technology Services sector. Here’s a quick read on where the business and the stock stand today.
HCL drops 19.6% over three months and trades near its 52-week lows. The PEG stands at 4.64 — severely stretched. Any earnings miss could trigger a sharp de-rating. D/E stands at 0.09 with a 7.86% dividend yield. Furthermore, the business records zero revenue dips and zero loss quarters in five years — a fortress balance sheet. The stock gains 5.2% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 8.7% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of HCL Technologies Limited.
HCLTECH
HCL Technologies Limited (HCLTECH) gains 5% intraday on heavy volume
HCL Technologies Limited (HCLTECH) stock moves up 5% intraday to ₹1224.3, showing a strong upward trend despite a breakdown status.
HCL Technologies Limited (HCLTECH) breaks out with a +5% gain, clearing its 6M resistance trendline. The stock’s move is driven by technical factors, specifically the breakout above the ₹1180 resistance level. HCLTECH operates in the technology sector, providing information technology services. Today’s move appears to be company-specific rather than a sector-wide trend, highlighting HCLTECH’s unique position within the IT services landscape.
Technical setup — trendlines & DMA
The current trendline structure shows a 6M support floor at ₹1009.61, which is 17.54% below today’s price, indicating a solid support base. Resistance was previously at ₹1179.58, which the stock has now broken, signaling potential for further upside. The 50-DMA at ₹1149.8 is slightly below today’s price, while the 200-DMA at ₹1428.9 remains above, suggesting a bearish trend in the longer term but a possible short-term recovery. The stock is currently in the lower third of its 52W range, implying there may be room for further gains if momentum continues.
Snapshot: ₹1,224.30 on 2026-07-13 (chart frozen at publication)
Fundamentals & business context
With a PE of 19.0, HCLTECH’s valuation seems stretched given its 12.8% profit margin and 8.7% revenue CAGR. This suggests the market may be pricing in future growth or a turnaround, despite current earnings. The 28.5% institutional ownership indicates that smart money has a moderate level of confidence in the company, though not overwhelmingly so. There was no NSE catalyst today, so the move is purely technical.
Algorithmic scorecard
The overall scorecard reflects a balanced but cautious view of HCLTECH, with strengths and weaknesses on both the fundamental and technical fronts. One of the strongest signals is the excellent dividend yield of 8.38%, offering high income potential, and the very low debt level with a D/E ratio of 0.09, indicating strong financial health. On the weaker side, the stock’s overvalued PEG ratio of 4.87 suggests it may be expensive relative to its growth rate, and the bearish trend indicated by the 50-DMA being below the 200-DMA raises concerns about longer-term momentum.
Company outlook
Management provided forward guidance for FY’27, targeting revenue growth of 1% to 4% in constant currency and 1.5% to 4.5% for Services. The EBIT margin is expected to be between 17.5% and 18.5%. The outlook hinges on maintaining planned revenue from two key clients and the trajectory of discretionary spend. At the higher end of guidance, a moderate increase in discretionary spend and the materialization of a couple of large deals in the first half are anticipated. The guidance does not include the acquisitions of Telecom Solutions Group from HPE and Jaspersoft due to delayed US government approval. The company is on track with its mega deal ramp-up to offset headwinds and expects deal TCV to remain around $2 billion due to AI impacts. Strategic plans include launching new AI Force SKUs for SAP and MedTech, and unveiling AI Force 2.0 and 2.1 releases. The software segment is pivoting towards more subscription and steady revenue streams, moving away from perpetual license sales.
Get all details on HCLTECH — P&L, peers, shareholding and more on TradeAlone.
HCLTECH
HCL Technologies Limited (NSE: HCLTECH) climbs 6% intraday
HCL Technologies Limited (NSE: HCLTECH) stock rises 6% intraday to ₹1144.2, approaching resistance at ₹1180.
HCL Technologies Limited (HCLTECH) climbed 6% to ₹1144.2 on the NSE on 03 Jul 2026. The move follows the company’s announcement of bagging new orders and contracts, as well as the completion of the acquisition of Jaspersoft. Despite today’s rise, the stock remains in a consolidating downtrend over the past six months, indicating a weak structure. HCLTECH operates in the technology sector, specifically information technology services, and today’s move appears to be driven by company-specific news rather than broader sector momentum.
Technical setup — trendlines & DMA
The current trendline structure for HCLTECH shows a breakdown, with the stock trading below both its 50-day and 200-day moving averages. The 6-month support trendline is at ₹1052.98, approximately 8% below today’s price, while resistance is at ₹1180, about 3% above. The stock is currently in the lower third of its 52-week range, suggesting that while there is room for further upside, the move today has not yet cleared significant resistance levels. The bearish trend indicated by the moving averages suggests that the stock is still under pressure despite today’s gains.
Snapshot: ₹1,144.20 on 2026-07-03 (chart frozen at publication)
Fundamentals & business context
With a PE of 17.6 and profit margins at 12.8%, HCLTECH’s valuation appears stretched relative to its current earnings, especially given its revenue CAGR of 8.7%. The market may be pricing in expectations of a turnaround or future growth, but the current valuation does not reflect the company’s immediate earnings power. Institutional ownership stands at 28.4%, indicating a moderate level of confidence from smart money, though not overwhelmingly bullish. There was no specific NSE catalyst today beyond the corporate announcements.
Algorithmic scorecard
The overall algorithmic scorecard for HCLTECH reflects a balanced but cautious outlook, with strengths in dividend yield and low debt offset by weaknesses in overvaluation relative to growth and a bearish technical trend. The strong dividend yield of 9.28% offers attractive income potential, while the very low debt level of 0.09 D/E ratio indicates excellent financial health. On the flip side, the overvalued PEG of 4.51 suggests the stock may be priced too high for its growth rate, and the bearish trend signaled by the moving averages points to ongoing technical weakness. Investors should weigh these factors carefully.
Company outlook
Management provided forward guidance for FY’27, projecting revenue growth of 1% to 4% in constant currency and 1.5% to 4.5% for Services. EBIT margin guidance is set between 17.5% to 18.5%. The outlook hinges on planned revenue from two clients and the trajectory of discretionary spend, with the higher end of growth depending on a pick-up in spend and the materialization of large deals in the first half. Notably, the guidance excludes the impact of recent acquisitions due to delayed US government approval. The company is on track with its mega deal ramp-up to offset headwinds and expects deal TCV to remain around $2 billion due to AI impact. Strategic plans include launching new AI Force SKUs for SAP and MedTech, and pivoting the software segment towards subscription and steady revenue streams.
Get all details on HCLTECH — P&L, peers, shareholding and more on TradeAlone.
-
Healthcare2 days agoZydus Lifesciences Limited (zyduslife) USFDA Inspection of Pharmacovigilance Concludes with Nil Observations
-
Beverages - Brewers2 days agoSom Distilleries & Breweries Limited (sdbl): Court Judgment Clears Path for Licence Renewal
-
Solar2 days agoSwelect Energy Systems Limited Expands C&I Energy Solutions Portfolio with Rollout of SWEES EN+ Solar Hybrid Inverter Range
-
AUGMONT2 days agoAugmont Enterprises Limited (augmont) Empanelled by NSE for Promotion of Electronic Gold Receipts (EGR)
-
Consumer Defensive11 hours agoRadico Khaitan Limited Expands Global Reach: Indian Luxury Whisky Brands Land in the Home of Scotch
-
Healthcare11 hours agoLupin Limited (lupin) Receives Tentative FDA Approval for Apixaban Oral Suspension
-
Healthcare12 hours agoSun Pharmaceutical Industries Limited (sunpharma) Secures Global Licensing for Lerodalcibep, a PCSK9 Inhibitor
-
Capital Markets11 hours agoIndian Energy Exchange Limited Expands Energy Markets Footprint
